Clostridium novyi-NT

· MD Anderson Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Clostridium novyi-NT, covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT [Phase 1]